Stock Rich List
#7509 on the rich list of 14,452 insiders

Matthias Bodenstedt

Chief Financial Officer at MoonLake Immunotherapeutics.

$12.3M
in disclosed stock, +$268K (+2.22%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
7509th of 14,452
Companies held
1
Largest holding
MLTX, 100.0% of total
Latest SEC filing
Jun 22, 2026

What the $12.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
Directly1,115,435$11.03$12.3M100.0%Form 4, Jun 22, 2026

Share counts are the amounts Matthias Bodenstedt reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jun 22, 2026SoldMLTX39,120$22.04$862KView
Jun 18, 2026SoldMLTX2,794$19.60$55KView
Jun 17, 2026SoldMLTX15,082$19.68$297KView
May 11, 2026SoldMLTX13,653$20.02$273KView
Apr 14, 2026SoldMLTX2,426$19.56$47KView
Apr 10, 2026SoldMLTX1,925$19.51$38KView
Apr 9, 2026SoldMLTX85,870$18.94$1.6MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
7506Sheara J. Fredman
Chief Accounting Officer, The Goldman Sachs Group. New York, NY
$12.3M−$373K (−2.94%)
7507John A. Thain
Director, Uber Technologies. San Francisco, CA
$12.3M−$593K (−4.60%)
7508Amy Christine Friedrich
President - Benefits & Protect, Principal Financial Group. Des Moines, IA
$12.3M−$372K (−2.94%)
7509Matthias Bodenstedt
Chief Financial Officer, MoonLake Immunotherapeutics
$12.3M+$268K (+2.22%)
7510Jacqueline B. Kosecoff
Director, STERIS. Dublin, CA
$12.3M−$298K (−2.37%)
7511Harry Sommer
Pres. & CEO of NCLH, Norwegian Cruise Line Holdings. Miami, FL
$12.3M−$663K (−5.11%)
7512Duncan P. Hennes
Director, Citigroup. New York, NY
$12.3M−$193K (−1.54%)

Other MoonLake Immunotherapeutics insiders

All MLTX insiders

Questions

How much stock does Matthias Bodenstedt own?

Matthias Bodenstedt holds $12,303,248 in listed stock based on SEC filings and current prices, mostly MoonLake Immunotherapeutics (MLTX). That ranks 7509th on the Stock Rich List.

Is this Matthias Bodenstedt's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Matthias Bodenstedt last buy or sell stock?

The most recent open-market trade on file is a sale of 39,120 MLTX shares on Jun 22, 2026 at $22.04.